Correlation Between Graphite Bio and NextCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Graphite Bio and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Graphite Bio and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Graphite Bio and NextCure, you can compare the effects of market volatilities on Graphite Bio and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Graphite Bio with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Graphite Bio and NextCure.

Diversification Opportunities for Graphite Bio and NextCure

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Graphite and NextCure is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Graphite Bio and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Graphite Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Graphite Bio are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Graphite Bio i.e., Graphite Bio and NextCure go up and down completely randomly.

Pair Corralation between Graphite Bio and NextCure

Given the investment horizon of 90 days Graphite Bio is expected to generate 0.8 times more return on investment than NextCure. However, Graphite Bio is 1.25 times less risky than NextCure. It trades about 0.09 of its potential returns per unit of risk. NextCure is currently generating about 0.01 per unit of risk. If you would invest  185.00  in Graphite Bio on August 28, 2024 and sell it today you would earn a total of  82.00  from holding Graphite Bio or generate 44.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy28.78%
ValuesDaily Returns

Graphite Bio  vs.  NextCure

 Performance 
       Timeline  
Graphite Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Graphite Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Graphite Bio is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Graphite Bio and NextCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Graphite Bio and NextCure

The main advantage of trading using opposite Graphite Bio and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Graphite Bio position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.
The idea behind Graphite Bio and NextCure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance